Is Vidarabine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Vidarabine.

Is Vidarabine approved by the US FDA?

Drugs@FDA lists 2 application product lines for Vidarabine, including VIRA-A (Discontinued); VIRA-A (Discontinued).

Active substance

Vidarabine

SFDA 1
US FDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
VIDARABINE 3% THILO-EYE OINT.	3 %	Ointment · Ophthalmic use	1 Tube	SAR 26.20	NCE · Prescription	DR. THILO LABORATORIES	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
VIRA-A	3%	ointment · ophthalmic	PARKEDALE	Discontinued	26 Nov 1976
VIRA-A	EQ 187.4MG BASE/ML	injectable · injection	PARKEDALE	Discontinued	18 Oct 1978

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.